Intellectual Property Magazine
Perfect partners
How pharma and biotech can get the best out of licensing and collaborations
The increasing prevalence of cell and gene therapies is driving a continued focus on licence and collaboration agreements
as mid to large-cap pharmaceutical companies (pharma) seek to tap into platform technologies developed by biotechnology companies
(biotechs).